“We will Appraise how the commercialization of this substance suits in with our company design at Adastra in an effort to placement ourselves to aid the need for a secure supply of copyright,” explained Main executive officer Michael Forbes inside a information release. The business explained to VICE News it wouldn't be commenting further. C